These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 377888)

  • 21. Somatostatin. Its possible role in carbohydrate homeostasis and the treatment of diabetes mellitus.
    Gerich JE
    Arch Intern Med; 1977 May; 137(5):659-66. PubMed ID: 324423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Inhibition of gastrin and gastric acid by growth hormone release inhibiting hormone.
    Bloom SR; Russell RC; Barros-D'sa AA; Baron JH; Besser GM; Hall R; Coy H; Kastin AJ; Schally AV
    Gut; 1975 May; 16(5):396. PubMed ID: 1140650
    [No Abstract]   [Full Text] [Related]  

  • 23. "Big big" gastrin release by the isolated islets of Langerhans incubated in vitro.
    Rotllan P; García-Hermida O; Gómez-Acebo J
    Rev Esp Fisiol; 1980 Mar; 36(1):57-61. PubMed ID: 6994179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of somatostatin receptors involved in inhibition of gastric acid and growth hormone secretion with halogenated Trp8 analogues [proceedings].
    Coy DH; Hirst BH; Meyers CA; Reed JD; Schally AV
    J Physiol; 1978 Dec; 285():40P. PubMed ID: 217989
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial: Somatostatin (somatotrophin release inhibiting factor).
    S Afr Med J; 1974 Jun; 48(28):1180. PubMed ID: 4599981
    [No Abstract]   [Full Text] [Related]  

  • 26. Investigation of gastrin activity in pancreatic islet tissue.
    Blair EL; Falkmer S; Hellerström C; Ostberg H; Richardson DD
    Acta Pathol Microbiol Scand; 1969; 75(4):583-97. PubMed ID: 4911528
    [No Abstract]   [Full Text] [Related]  

  • 27. Somatostatin: a review of its effects especially in human beings.
    Hansen AP; Lundbaek K
    Diabete Metab; 1976 Dec; 2(4):203-18. PubMed ID: 190058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic function in patients with Zollinger-Ellison syndrome. Observations concerning acid-bicarbonate secretion ratios.
    Dreiling DA; Greenstein A
    Am J Gastroenterol; 1972 Jul; 58(1):66-72. PubMed ID: 4558375
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.
    Colturi TJ; Unger RH; Feldman M
    J Clin Invest; 1984 Aug; 74(2):417-23. PubMed ID: 6146638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of somatostatin analogue (SMS 201-995) on molecular species of gastrin in gastrinoma.
    Campagnolo D; Gower WR; Fabri PJ; Sparks J; Mekhjian HS; O'Dorisio TM; Ellison EC
    Surgery; 1987 Dec; 102(6):982-7. PubMed ID: 2891204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Somatostatin, a new hormone? (author's transl)].
    Assan R
    Diabete Metab; 1976 Sep; 2(3):135-46. PubMed ID: 795689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical aspects of gastrointestinal hormones.
    Lamers CB
    Neth J Med; 1978; 21(2):77-82. PubMed ID: 206847
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical recovery owing to target parietal cell failure in a patient with Zollinger-Ellison syndrome.
    Wiersinga WM; Tytgat GN
    Gastroenterology; 1977 Dec; 73(6):1413-7. PubMed ID: 199524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of somatostatin on gastrin release and gastric secretion.
    Schrumpf E; Vatn MH; Hanssen KF; Semb LS; Myren J
    Scand J Gastroenterol Suppl; 1976; 42():41-2. PubMed ID: 1070794
    [No Abstract]   [Full Text] [Related]  

  • 35. [Somatostatin--a hypothalamic factor inhibiting the secretion of growth hormone].
    Lankosz-Lauterbach J
    Pediatr Pol; 1977 Aug; 52(8):919-23. PubMed ID: 333364
    [No Abstract]   [Full Text] [Related]  

  • 36. Somatostatin, 1976.
    Pimstone BL; Berelowitz M; Kronheim S
    S Afr Med J; 1976 Sep; 50(38):1471-4. PubMed ID: 9697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin inhibits insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF) in duodenal ulcer patients.
    Schrumpf E; Vatn MH; Hanssen KF; Semb S; Myren J
    Scand J Gastroenterol; 1976; 11(5):517-20. PubMed ID: 785589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acid secretion, plasma gastrin levels and the diagnosis of the Zollinger-Ellison syndrome.
    Lewin MR; Stagg BH; Clark CG
    Gut; 1972 Oct; 13(10):849. PubMed ID: 5087103
    [No Abstract]   [Full Text] [Related]  

  • 39. [Zollinger-Ellison syndrome type II. Preoperative diagnosis by means of gastrin stimulation tests].
    Arenas Mirave JI; Chantar C; Escartin P; Boixeda D; Pina R; Hernández Ranz F; Gil P
    Rev Clin Esp; 1978 Feb; 148(4):411-4. PubMed ID: 653064
    [No Abstract]   [Full Text] [Related]  

  • 40. [Demonstration of gastro-secretogogue activity of pancreatic origin. Apropos of a case of insinoma and 3 cases of Zollinger-Ellison syndrome].
    Debray C; Hardouin JP; Vasseur B; Cerf M; Martin E; Mignon M; Gouin B
    Ann Med Interne (Paris); 1969 Jan; 120(1):37-47. PubMed ID: 4304119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.